Services

Supply Chain Optimization​

We collaborate with your team to translate product forecasts into executable capacity plans, tech-transfers and registration timelines. Our approach blends demand modeling, supplier segmentation, CMO sourcing strategies and regulatory sequencing so launches aren’t constrained by supply. We deliver replicable playbooks that convert tactical decisions into portfolio-level resilience.​

Case Studies

Cross-functional Technical Product Team & Capacity Plan for Complex ADC​

 

Enablement of on-time global launch for a complex ADC by mobilizing a Technical Product Team and an integrated 12-quarter capacity plan.

Insights

Challenge: A global biopharma client launching a complex ADC faced insufficient launch capacity across raw materials, conjugation, and fill/finish due to capital constraints and staggered approvals.

Approach: We mobilized a TPT — Technical Product Leader, Demand Forecasters, Supply Lead, CMC/Regulatory, Quality, Manufacturing, and Tech-Transfer leads — back-calculated demand by phase, identified nine additional nodes across the value chain, and assessed sourcing options including greenfield, CMO slots, and strategic co-investment.

Impact: The client executed site additions and partner slot buys per the TPT roadmap, achieving on-time, in-full global launch without supply as a gating constraint. The TPT model was adopted portfolio-wide.

Inventory & Dual-Sourcing Redesign for Global Launch Readiness

 

Reduction of stockout risk and improved launch readinessfor a geographically dispersed portfolio by redesigninginventory and dual-sourcing strategies.

Insights

Challenge: A confidential portfolio with staggered country launches had uneven safety-stock policies and single-source dependencies. Regulatory timing variability and long lead times created stockout and bridging-stock risk, threatening timelines and working capital.

Approach: We segmented SKUs and suppliers by criticality, built demand-driven safety-stock rules tied to approval risk, and developed dual-sourcing playbooks. Scenario models quantified contingency needs, and we established backstop CMO slots and a cadence for supplier monitoring and rapid slot activation.

Impact: The client reduced single-source exposure, had contingency plans across all launch-critical SKUs, and gained clearer inventory forecasts — lowering stockout risk and improving supply confidence with product strategy stakeholders.

Supply Chain and Network Strategy for a Pre- Launch Gene Therapy Company

 

Development of a flexible 5-year supply strategy that cut capacity costs by 25% while reducing supply risk and supporting commercial and clinical gene therapy demand.​

Insights

Challenge: A client transitioning from clinical to commercial manufacturing for a complex gene therapy needed to balance cost and supply risk. Goals included reducing CMO dependence, lowering operational complexity, gaining capacity flexibility, and managing supply risk across commercial and clinical demand.

Approach: We analyzed the current supply network across cost, risk, and flexibility, developed future network options with demand scenarios, and built a five-year investment model covering both drug and vector manufacturing.

Impact: We delivered a clear 5-year network strategy backed by robust analysis, ready for immediate execution — reducing manufacturing capacity costs by 25% while managing supply risk and maintaining required service levels.

​